Taros announces appointment of new Director of Medicinal Chemistry
Taros Chemicals GmbH & Co. KG announced the appointment of Mr. Fabrizio Giordanetto, Ph.D., as Director of medicinal chemistry.
Fabrizio Giordanetto is an internationally renowned medicinal chemist with more than 10 years of successful track record in drug discovery gained in various scientific management positions with Pharmacia (Pfizer), Italy and AstraZeneca, Sweden.
Prior to joining Taros he led several drug discovery projects resulting in multiple clinical candidates spanning oncology and cardiovascular indications, more than 80 peer-reviewed publications, book chapters and international patents. Fabrizio Giordanetto completed his Ph.D. in Computational Medicinal Chemistry in 2003 at the University of London, UK. He brings a wealth of experience in medicinal chemistry and in the development of drug candidates that will complement Taros' longstanding efficiency in the synthetic chemistry business.
Fabrizio Giordanetto will lead the medchem team and expand our portfolio of services along the idea of combining extensive "big pharma know how" with SME efficiency and speed.
Other news from the department people
